223 related articles for article (PubMed ID: 19761871)
21. Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review.
Socha P; Horvath A; Vajro P; Dziechciarz P; Dhawan A; Szajewska H
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):587-96. PubMed ID: 19412008
[TBL] [Abstract][Full Text] [Related]
22. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis.
Sanyal AJ; Mofrad PS; Contos MJ; Sargeant C; Luketic VA; Sterling RK; Stravitz RT; Shiffman ML; Clore J; Mills AS
Clin Gastroenterol Hepatol; 2004 Dec; 2(12):1107-15. PubMed ID: 15625656
[TBL] [Abstract][Full Text] [Related]
23. Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.
Nadeau KJ; Ehlers LB; Zeitler PS; Love-Osborne K
Pediatr Diabetes; 2009 Feb; 10(1):5-13. PubMed ID: 18721166
[TBL] [Abstract][Full Text] [Related]
24. Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial.
Anushiravani A; Haddadi N; Pourfarmanbar M; Mohammadkarimi V
Eur J Gastroenterol Hepatol; 2019 May; 31(5):613-617. PubMed ID: 30920975
[TBL] [Abstract][Full Text] [Related]
25. Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease.
Kadayifci A; Merriman RB
Am J Gastroenterol; 2006 Jun; 101(6):1396; author reply 1396-7. PubMed ID: 16771968
[No Abstract] [Full Text] [Related]
26. Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease.
Lin CH; Kohli R
Curr Gastroenterol Rep; 2020 Aug; 22(10):52. PubMed ID: 32814993
[TBL] [Abstract][Full Text] [Related]
27. Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial.
Sofer E; Boaz M; Matas Z; Mashavi M; Shargorodsky M
Metabolism; 2011 Sep; 60(9):1278-84. PubMed ID: 21411114
[TBL] [Abstract][Full Text] [Related]
28. Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Sato K; Gosho M; Yamamoto T; Kobayashi Y; Ishii N; Ohashi T; Nakade Y; Ito K; Fukuzawa Y; Yoneda M
Nutrition; 2015; 31(7-8):923-30. PubMed ID: 26059365
[TBL] [Abstract][Full Text] [Related]
29. Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease.
Yates KP; Deppe R; Comerford M; Masuoka H; Cummings OW; Tonascia J; Chalasani N; Vuppalanchi R;
PLoS One; 2017; 12(11):e0185813. PubMed ID: 29095942
[TBL] [Abstract][Full Text] [Related]
30. Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials.
Brunt EM; Kleiner DE; Wilson LA; Sanyal AJ; Neuschwander-Tetri BA;
Hepatology; 2019 Aug; 70(2):522-531. PubMed ID: 30549292
[TBL] [Abstract][Full Text] [Related]
31. No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial.
Sanyal AJ; Abdelmalek MF; Suzuki A; Cummings OW; Chojkier M;
Gastroenterology; 2014 Aug; 147(2):377-84.e1. PubMed ID: 24818764
[TBL] [Abstract][Full Text] [Related]
32. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A
Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142
[TBL] [Abstract][Full Text] [Related]
33. Randomized, vitamin E-controlled trial of bicyclol plus metformin in non-alcoholic fatty liver disease patients with impaired fasting glucose.
Han Y; Shi JP; Ma AL; Xu Y; Ding XD; Fan JG
Clin Drug Investig; 2014 Jan; 34(1):1-7. PubMed ID: 24081374
[TBL] [Abstract][Full Text] [Related]
34. Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial.
Bril F; Biernacki DM; Kalavalapalli S; Lomonaco R; Subbarayan SK; Lai J; Tio F; Suman A; Orsak BK; Hecht J; Cusi K
Diabetes Care; 2019 Aug; 42(8):1481-1488. PubMed ID: 31332029
[TBL] [Abstract][Full Text] [Related]
35. Treatment of non-alcoholic steatohepatitis with Phyllanthus urinaria: a randomized trial.
Wong VW; Wong GL; Chan AW; Chu WC; Choi PC; Chim AM; Yiu KK; Yu J; Chan FK; Chan HL
J Gastroenterol Hepatol; 2013 Jan; 28(1):57-62. PubMed ID: 23034128
[TBL] [Abstract][Full Text] [Related]
36. Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.
Janczyk W; Lebensztejn D; Wierzbicka-RuciĆska A; Mazur A; Neuhoff-Murawska J; Matusik P; Socha P
J Pediatr; 2015 Jun; 166(6):1358-63.e1-3. PubMed ID: 25771388
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver.
Akcam M; Boyaci A; Pirgon O; Kaya S; Uysal S; Dundar BN
Int J Vitam Nutr Res; 2011 Nov; 81(6):398-406. PubMed ID: 22673924
[TBL] [Abstract][Full Text] [Related]
38. Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.
Loomba R; Lutchman G; Kleiner DE; Ricks M; Feld JJ; Borg BB; Modi A; Nagabhyru P; Sumner AE; Liang TJ; Hoofnagle JH
Aliment Pharmacol Ther; 2009 Jan; 29(2):172-82. PubMed ID: 18945255
[TBL] [Abstract][Full Text] [Related]
39. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
Pervez MA; Khan DA; Ijaz A; Khan S
Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
[TBL] [Abstract][Full Text] [Related]
40. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
Askari F; Rashidkhani B; Hekmatdoost A
Nutr Res; 2014 Feb; 34(2):143-8. PubMed ID: 24461315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]